Twist Bioscience Insider Trades: CEO and CFO Sell‑to‑Cover Stocks as RSU Vesting Continues—No Red Flag for Investors

Insider Selling Continues at Twist Bioscience

On May 4, 2026, Cho Dennis – listed in the SEC filing as “See Remarks” – executed a sell‑to‑cover transaction of 1,962 shares of Twist Bioscience common stock. The shares were sold at the prevailing market price of $59.53, leaving Dennis with 135,941 shares. This sale is part of a series of routine “sell‑to‑cover” trades that satisfy the company’s equity‑incentive plan tax‑withholding requirements, rather than a discretionary liquidation of long‑term holdings.

What Does This Mean for Investors? The transaction is consistent with the pattern of Dennis’s recent filings. Over the past 15 months, he has sold a cumulative 14,500 shares, with average prices ranging from $32 to $50 per share, and typically in modest blocks (hundreds to a few thousand). These moves have not materially altered his stake, which remains in the 130,000–145,000 share range. For the market, the sell‑to‑cover activity signals that Dennis’s equity grant is vesting and the tax liability is being met, but it does not indicate a change in confidence in the company’s prospects. The broader insider activity—CEO Emily Leproust has sold 5,127 shares on the same day, and the COO and CFO have also disclosed trades—suggests that the executive team is engaging in standard portfolio management rather than a coordinated divestiture.

Implications for Twist’s Outlook Twist’s recent earnings report shows a 19 % revenue lift, yet earnings per share remain negative, with a P/E of –44.57. The company’s market cap of $3.45 billion and a 52‑week high of $66.06 reflect a cautious but optimistic investor base. The timing of the sell‑to‑cover trades coincides with the company’s quarterly filing, a period when many insiders must settle tax obligations. This routine activity should not be viewed as a red flag. Instead, it underscores the company’s compliance posture and the executives’ adherence to regulatory requirements.

Profile: Cho Dennis Dennis is a senior legal officer and corporate secretary who has been with Twist since its early expansion phase. His insider history is dominated by “sell‑to‑cover” trades under the company’s restricted‑stock‑unit (RSU) program. The volume of his sales has remained modest, and the average price per share has trended upward, mirroring the company’s share price appreciation. Historically, Dennis has not engaged in large block trades that could signal a shift in strategy. His current transaction follows the established pattern: a routine tax‑withholding sale that keeps his holdings intact while fulfilling contractual obligations.

Takeaway for Portfolio Managers Given the pattern of transactions, investors can interpret Dennis’s sell‑to‑cover activity as a normal vesting and tax‑settlement event rather than a signal of impending distress or strategic shift. The broader insider activity at Twist, including sales by the CEO, COO, and CFO, reflects routine portfolio management. Investors should continue monitoring the company’s financial health—particularly its transition to profitability—and any significant changes in insider holdings or large block trades that could indicate a more substantive change in sentiment.